Literature DB >> 17406914

Renal medullary carcinoma: unsuspected diagnosis at stone protocol CT.

Amy Neville1, Stephen F Hatem.   

Abstract

Renal medullary carcinoma (RMC) is an aggressive neoplasm occurring almost exclusively in adolescents and young adults with sickle cell (SC) hemoglobinopathies, usually sickle cell trait (SCT) or hemoglobin SC disease. The most common presentations are hematuria and flank or abdominal pain. It is a highly malignant tumor, and responses to chemotherapy are rare and transient resulting in a dismal prognosis. A high level of suspicion is necessary when evaluating at risk patients presenting with hematuria or flank pain, as currently it appears that only early diagnosis could potentially alter the outcome of this disease. We report a case of RMC in a young male patient with SCT, who presented to the emergency department with low back pain and microscopic hematuria, clinically mimicking acute obstructing urolithiasis. Our case emphasizes the need to consider alternate diagnoses when evaluating computed tomography scans for acute flank pain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406914     DOI: 10.1007/s10140-007-0596-y

Source DB:  PubMed          Journal:  Emerg Radiol        ISSN: 1070-3004


  15 in total

1.  Renal medullary carcinoma: can early diagnosis lead to long-term survival?

Authors:  D M Selby; C Simon; J P Foley; I M Thompson; R T Baddour
Journal:  J Urol       Date:  2000-04       Impact factor: 7.450

2.  Nonobstructive renal causes of flank pain: findings on noncontrast helical CT (CT KUB).

Authors:  L Talner; M Vaughan
Journal:  Abdom Imaging       Date:  2003 Mar-Apr

3.  Renal medullary carcinoma: sonographic, computed tomography, magnetic resonance and angiographic findings.

Authors:  A Khan; N Thomas; B Costello; L Jobling; D deKretser; E Broadfield; S O'Shea
Journal:  Eur J Radiol       Date:  2000-07       Impact factor: 3.528

Review 4.  Significant responses to platinum-based chemotherapy in renal medullary carcinoma.

Authors:  John J Strouse; Melissa Spevak; A Kyle Mack; Robert J Arceci; Donald Small; David M Loeb
Journal:  Pediatr Blood Cancer       Date:  2005-04       Impact factor: 3.167

5.  Renal medullary carcinoma: CT and MRI features.

Authors:  Netta M Blitman; Robert G Berkenblit; Alla M Rozenblit; Terry L Levin
Journal:  AJR Am J Roentgenol       Date:  2005-07       Impact factor: 3.959

6.  Impact of abdominal CT on the management of patients presenting to the emergency department with acute abdominal pain.

Authors:  M P Rosen; D Z Sands; H E Longmaid; K F Reynolds; M Wagner; V Raptopoulos
Journal:  AJR Am J Roentgenol       Date:  2000-05       Impact factor: 3.959

7.  Renal medullary carcinoma and ABL gene amplification.

Authors:  Lijo Simpson; Xiang He; Michael Pins; Xiaoke Huang; Steven C Campbell; Ximing J Yang; Elizabeth J Perlman; Raymond C Bergan
Journal:  J Urol       Date:  2005-06       Impact factor: 7.450

Review 8.  Renal medullary carcinoma in an adolescent with sickle cell trait.

Authors:  K E Warren; V Gidvani-Diaz; B Duval-Arnould
Journal:  Pediatrics       Date:  1999-02       Impact factor: 7.124

Review 9.  Unenhanced helical CT in the investigation of acute flank pain.

Authors:  Robert Colistro; William C Torreggiani; Iain D Lyburn; Alison C Harris; Nizar A Al-Nakshabandi; Savvas Nicolaou; Peter L Munk
Journal:  Clin Radiol       Date:  2002-06       Impact factor: 2.350

10.  Renal medullary carcinoma. The seventh sickle cell nephropathy.

Authors:  C J Davis; F K Mostofi; I A Sesterhenn
Journal:  Am J Surg Pathol       Date:  1995-01       Impact factor: 6.394

View more
  2 in total

1.  Clinical and computed tomography imaging features of renal medullary carcinoma: A report of six cases.

Authors:  Zhenshan Shi; Qian Zhuang; Ruixiong You; Yueming Li; Jian Li; Dairong Cao
Journal:  Oncol Lett       Date:  2015-11-09       Impact factor: 2.967

Review 2.  Imaging of Renal Medullary Carcinoma.

Authors:  Federico Greco; Eliodoro Faiella; Domiziana Santucci; Carlo Augusto Mallio; Marco Nezzo; Carlo Cosimo Quattrocchi; Bruno Beomonte Zobel; Rosario Francesco Grasso
Journal:  J Kidney Cancer VHL       Date:  2017-03-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.